NRx Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Results Focusing on Reactivation & Advancement of its Psychiatry Franchise

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to NRx Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Results Focusing on Reactivation & Advancement of its Psychiatry Franchise
(NASDAQ: NRXP) Delayed: 3.76 -0.14 (3.59%)
Previous Close $3.90    52 Week High $ 
Open $3.80    52 Week Low $ 
Day High $3.93    P/E N/A 
Day Low $3.72    EPS $ 
Volume 800,233